Clinical Trial Update: Evaluating the Risk of Serious Ventricular Arrhythmia and Sudden Cardiac Death Among Users of Domperidone

View source ↗

Summary

A completed clinical trial update evaluated the risk of ventricular arrhythmia and sudden cardiac death among domperidone users.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Sudden Cardiac Death
• Ventricular Arrhythmia

Drugs mentioned

• Domperidone (domperidone)

Snippet

Sponsor: Johnson & Johnson Pharmaceutical Research & Development, L.L.C. | Conditions: Arrhythmias, Cardiac | Status: COMPLETED